Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 105,940 | 69,948 | 63,476 | 48,651 | 37,197 |
| Operating Income | -105,940 | -69,948 | -63,476 | -48,651 | -37,197 |
| Interest Expense | 3,931 | 602 | 159 | 593 | 665 |
| Other Income | -3,347 | 725 | -7,455 | -1,330 | 976 |
| Pre-tax Income | -113,218 | -69,825 | -71,090 | -50,574 | -36,886 |
| Net Income Continuous | -113,218 | -69,825 | -71,090 | -50,574 | -36,886 |
| Net Income | $-113,218 | $-69,825 | $-71,090 | $-50,574 | $-36,886 |
| EPS Basic Total Ops | -1.81 | -1.10 | -1.12 | -0.87 | -0.66 |
| EPS Basic Continuous Ops | -1.80 | -1.10 | -1.12 | -0.87 | -0.67 |
| EPS Diluted Total Ops | -1.81 | -1.10 | -1.12 | -0.87 | -0.66 |
| EPS Diluted Continuous Ops | -1.80 | -1.10 | -1.12 | -0.87 | -0.67 |
| EBITDA(a) | $-103,771 | $-69,557 | $-63,316 | $-48,433 | $-37,131 |